CCA
ALDR

Checchi Capital Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

Checchi Capital Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8
Closed – – 1412
2016
Q2 		$0 Hold
8
– – ﹤0.01% 1662
2016
Q1 		$0 Buy
+8
New +$185 ﹤0.01% 1630

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Checchi Capital Advisers's ALDR Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q3 2016, closing a stake of 8 shares.

Checchi Capital Advisers first reported a position in ALDR in Q1 2016 and held it in 2 quarters. The position peaked at $0 in Q2 2016. 159 funds tracked by Wall St. Rank hold ALDR as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Alder Biopharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 8 Alder Biopharmaceuticals shares in Q3 2016.
  • Checchi Capital Advisers first reported a position in Alder Biopharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Alder Biopharmaceuticals position peaked at $0 in Q2 2016.
  • 159 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.